Société TapImmune Inc. OTC Bulletin Board
Actions
TPIV
US8760334081
Recherche biotechnologique et médicale
Métier
Ventes par activité
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
Immunotherapies and Innovative Peptide-Based Vaccines
100,0
%
| 9 | 100,0 % | 3 | 100,0 % | -63,26% |
Ventes par région
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 9 | 100,0 % | 3 | 100,0 % | -63,26% |
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Juan Vera
CEO | Chief Executive Officer | 44 | 17/10/18 |
Monic Stuart
CTO | Chief Tech/Sci/R&D Officer | - | - |
Gerald Garrett
CTO | Chief Tech/Sci/R&D Officer | 59 | 01/11/19 |
Chief Tech/Sci/R&D Officer | 51 | 23/10/18 | |
Chief Administrative Officer | - | 01/09/15 | |
John Wilson
BRD | Director/Board Member | 64 | - |
Edmund Cheung
HRO | Human Resources Officer | - | 01/01/21 |
Nadia Agopyan
LAW | General Counsel | 62 | 15/08/19 |
General Counsel | 67 | 23/10/18 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Norman Eansor
CHM | Chairman | 63 | 17/10/18 |
Steven Elms
BRD | Director/Board Member | 60 | 06/08/19 |
Katharine Knobil
BRD | Director/Board Member | 60 | 08/12/21 |
John Wilson
BRD | Director/Board Member | 64 | - |
Juan Vera
CEO | Chief Executive Officer | 44 | 17/10/18 |
Coordonnées société
Marker Therapeutics, Inc.
4551 Kennedy Commerce Drive
77032, Houston
+713 400 6400
http://www.markertherapeutics.com![Adresse TapImmune Inc.(TPIV)](https://cdn.zonebourse.com/static/address/31370463.png)
Secteur
Varia. 1 janv. | Capi. | |
---|---|---|
+31,58% | 52,73 Md | |
+37,40% | 39 Md | |
-9,56% | 38,52 Md | |
+27,41% | 30,38 Md | |
-12,26% | 26,39 Md | |
+10,53% | 26,08 Md | |
+44,57% | 14,15 Md | |
+31,98% | 12,6 Md | |
-5,34% | 11,51 Md |